abrdn Healthcare Investors (HQH) Stock
Company insiders reported 0 open-market buys and 1 sale on SEC Form 4 in the 90 days to Nov 6, 2026.
Are abrdn Healthcare Investors insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Oct 6, 26 | Goodson Alan R | Director | SELL | 242.01 | $5K |
SEC Form 4 filings as of Nov 6, 2026
See cluster-buy signals across all tickers →HQH price chart
Powered by TradingViewWhat does abrdn Healthcare Investors do?
Tekla Healthcare Investors is a closed-end fund dedicated to investing in the healthcare sector, with a primary focus on achieving long-term capital appreciation. Managed by Tekla Capital Management LLC, this fund strategically invests in a diversified portfolio of healthcare-related securities, including biotechnology, pharmaceuticals, medical devices, and healthcare information technology. Its approach emphasizes exposure to both large, established firms and innovative growth companies, reflecting the evolving landscape of healthcare research and delivery. With origins dating back to its inception in 2011, Tekla Healthcare Investors has carved out a role as a sector specialist, capitalizing on key trends such as demographic changes, technological advancements, and rising global healthcare expenditures. The fund seeks to deliver value to its stakeholders through periodic distributions, typically on a quarterly basis, and maintains a sizable allocation to its top holdings, highlighting a concentrated yet diversified investment style. Tekla Healthcare Investors serves institutions and individuals seeking targeted access to healthcare market opportunities, providing a vehicle for participation in one of the economy’s most dynamic and resilient sectors.